CVS HEALTH Corp (CVS) stock
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3015% above fair value
$88.59−0.76 (-0.85%)
Close on Nov 16, 2026Market cap $113.30BP/E 23.5Yield 3.00%
Cvs Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cvs Health's total debt was $61.41B at Jun 30, 2026. For fiscal 2025 it was $64.57B, down 2.6% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $73.43B in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.57B | -2.6% |
| FY2024 | Dec 31, 2024 | $66.27B | +7.6% |
| FY2023 | Dec 31, 2023 | $61.61B | +17.9% |
| FY2022 | Dec 31, 2022 | $52.25B | -7.0% |
| FY2021 | Dec 31, 2021 | $56.18B | -13.1% |
| FY2020 | Dec 31, 2020 | $64.65B | -5.6% |
| FY2019 | Dec 31, 2019 | $68.48B | -6.7% |
| FY2018 | Dec 31, 2018 | $73.43B | +171.9% |
| FY2017 | Dec 31, 2017 | $27.00B | -1.9% |
| FY2016 | Dec 31, 2016 | $27.53B | +0.2% |
| FY2015 | Dec 31, 2015 | $27.46B | +113.1% |
| FY2014 | Dec 31, 2014 | $12.89B | -3.8% |
| FY2013 | Dec 31, 2013 | $13.40B | +36.4% |
| FY2012 | Dec 31, 2012 | $9.83B | -1.9% |
| FY2011 | Dec 31, 2011 | $10.01B | -0.4% |
| FY2010 | Dec 31, 2010 | $10.06B | -10.0% |
| FY2009 | Dec 31, 2009 | $11.18B | -4.9% |
| FY2008 | Dec 31, 2008 | $11.75B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $61.41B | -7.6% |
| Q1 FY2026 | Mar 31, 2026 | $63.11B | -2.5% |
| Q4 FY2025 | Dec 31, 2025 | $64.57B | -2.6% |
| Q3 FY2025 | Sep 30, 2025 | $65.84B | +0.5% |
| Q2 FY2025 | Jun 30, 2025 | $66.49B | +0.2% |
| Q1 FY2025 | Mar 31, 2025 | $64.71B | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $66.27B | +7.6% |
| Q3 FY2024 | Sep 30, 2024 | $65.53B | +5.8% |
| Q2 FY2024 | Jun 30, 2024 | $66.37B | +4.0% |
| Q1 FY2024 | Mar 31, 2024 | $64.14B | +10.2% |
| Q4 FY2023 | Dec 31, 2023 | $61.61B | +17.9% |
| Q3 FY2023 | Sep 30, 2023 | $61.91B | +18.6% |
| Q2 FY2023 | Jun 30, 2023 | $63.82B | +16.4% |
| Q1 FY2023 | Mar 31, 2023 | $58.23B | +3.5% |
| Q4 FY2022 | Dec 31, 2022 | $52.25B | -7.0% |
| Q3 FY2022 | Sep 30, 2022 | $52.21B | -10.6% |
| Q2 FY2022 | Jun 30, 2022 | $54.82B | -7.6% |
| Q1 FY2022 | Mar 31, 2022 | $56.28B | -9.1% |
| Q4 FY2021 | Dec 31, 2021 | $56.18B | -13.1% |
| Q3 FY2021 | Sep 30, 2021 | $58.39B | -12.8% |
| Q2 FY2021 | Jun 30, 2021 | $59.35B | -17.2% |
| Q1 FY2021 | Mar 31, 2021 | $61.94B | -13.7% |
| Q4 FY2020 | Dec 31, 2020 | $64.65B | -5.6% |
| Q3 FY2020 | Sep 30, 2020 | $67.00B | -3.0% |
| Q2 FY2020 | Jun 30, 2020 | $71.67B | +0.5% |
| Q1 FY2020 | Mar 31, 2020 | $71.82B | -4.0% |
| Q4 FY2019 | Dec 31, 2019 | $68.48B | -6.7% |
| Q3 FY2019 | Sep 30, 2019 | $69.05B | +9.8% |
| Q2 FY2019 | Jun 30, 2019 | $71.28B | +9.5% |
| Q1 FY2019 | Mar 31, 2019 | $74.79B | +14.9% |
| Q4 FY2018 | Dec 31, 2018 | $73.43B | +171.9% |
| Q3 FY2018 | Sep 30, 2018 | $62.89B | +143.8% |
| Q2 FY2018 | Jun 30, 2018 | $65.11B | +143.3% |
| Q1 FY2018 | Mar 31, 2018 | $65.09B | +137.3% |
| Q4 FY2017 | Dec 31, 2017 | $27.00B | -1.9% |
| Q3 FY2017 | Sep 30, 2017 | $25.79B | +7485.0% |
| Q2 FY2017 | Jun 30, 2017 | $26.76B | – |
| Q1 FY2017 | Mar 31, 2017 | $27.43B | – |
| Q4 FY2016 | Dec 31, 2016 | $27.53B | – |
| Q3 FY2016 | Sep 30, 2016 | $340.00M | – |
See a number that looks wrong?